Insiders · Profile

Russo Rene

PRESIDENT AND CEO at Xilio Therapeutics. Filing since 16 Jun 2025. CIK 0001722066

Company

Date

Role

Action

Shares

Amount

Of holding

XLO Xilio Therapeutics, Inc.

16 Jun 2025

PRESIDENT AND CEO

Bought

36,289

$24.68K

14.8%

1 decision on file.